executive in residence

Richard Gliklich, MD

Richard Gliklich, MD
Connect with

Richard Gliklich, MD

XIR, Founder, Better Outcome Partners, LLC Founder & CEO, OM1

As an XIR, Rich leverages his operational experience and domain expertise to support businesses in the healthcare and life sciences industries.

He is the CEO of OM1, a General Catalyst portfolio company which provides technology and expertise to enable healthcare organizations and other stakeholders to collect and leverage valid outcomes data. Previously, he was founder and CEO of Outcome, which he led from inception through its acquisition by Quintiles.

Rich is well known in the areas of registries, outcomes, and analytics. He is senior editor of the landmark publication by the U.S. Agency for Healthcare Research and Quality (AHRQ) handbook "Registries for Evaluating Patient Outcomes: A User's Guide” and the PI for the Outcomes Measures Framework, which focuses on standardization of outcomes measurement. He has led several key national and international efforts focused on evaluating the safety, effectiveness, value, and quality of healthcare. Dr. Gliklich also holds several patents for both health outcomes systems and medical devices.

Rich is a graduate of Yale University and Harvard Medical School and a former Charles A. Dana Scholar at the University of Pennsylvania. He is also a surgeon and the Leffenfeld Professor at Harvard Medical School.

Select Investments

No items found.

Alumni Highlights

No items found.
Full list of investments can be found here.